Definition:
The Digestives and Intestinal Remedies market comprises over-the-counter natural and synthetic digestive agents and remedies against gastrointestinal complaints. Digestives include preparations in the form of pills, powder, capsules, liquids, solutions, suspensions, drops and suppositories. Not included are prescription medicines, preparations that are against the state law or are not explicit digestive drugs (e.g. painkillers). Among the top-selling digestives are Perenterol, Iberogast, Dulcolax and Buscopan Plus. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.
Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.
Most recent update: Mar 2024
The Digestives & Intestinal Remedies market in Botswana is experiencing steady growth due to changing customer preferences and increasing awareness about digestive health.
Customer preferences: In recent years, there has been a shift in customer preferences towards natural and herbal remedies for digestive issues. Consumers are becoming more conscious about the ingredients and potential side effects of pharmaceutical products, leading them to seek alternative solutions. This trend is not unique to Botswana, but is seen worldwide as consumers prioritize their health and well-being.
Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Botswana is the growing demand for probiotics. Probiotics are live bacteria and yeasts that are beneficial for gut health. They help restore the natural balance of bacteria in the digestive system and improve overall digestion. As consumers become more aware of the importance of gut health, they are turning to probiotics as a natural and effective solution. This trend is also driven by the increasing availability of probiotic products in the market.Another trend in the market is the rising popularity of herbal remedies. Botswana has a rich tradition of herbal medicine, and many consumers are embracing traditional remedies for digestive issues. Herbal remedies are perceived as being more natural and gentle on the body compared to pharmaceutical products. This trend is in line with the global shift towards natural and holistic approaches to health and wellness.
Local special circumstances: Botswana has a relatively high prevalence of digestive disorders such as irritable bowel syndrome (IBS) and acid reflux. This can be attributed to factors such as changing dietary habits, stress, and sedentary lifestyles. The high incidence of these conditions creates a significant market opportunity for Digestives & Intestinal Remedies in the country.
Underlying macroeconomic factors: The growing middle class in Botswana is another factor driving the growth of the Digestives & Intestinal Remedies market. As disposable incomes increase, consumers are willing to spend more on healthcare products and are more likely to prioritize their digestive health. Additionally, the government of Botswana has been investing in healthcare infrastructure and promoting health awareness campaigns, which further contributes to the growth of the market.In conclusion, the Digestives & Intestinal Remedies market in Botswana is witnessing growth due to changing customer preferences towards natural and herbal remedies, the increasing demand for probiotics, the prevalence of digestive disorders, and the growing middle class. These factors, along with the government's focus on healthcare, are driving the market forward.
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Most recent update: Mar 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights